Real world outcomes using PD-1 antibodies and BRAF+MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland

Autor: Schumann, K, Mauch, C, Klespe, K C, et al, Dummer, Reinhard, Mangana, Johanna
Rok vydání: 2022
DOI: 10.5167/uzh-224122
Databáze: OpenAIRE